Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Metabolic surgery for type 2 diabetes

Clinicians note that bariatric operations can dramatically resolve type 2 diabetes, often before and out of proportion to postoperative weight loss. Now two randomized controlled trials formally show superior results from surgical compared with medical diabetes care, including among only mildly obese patients. The concept of 'metabolic surgery' to treat diabetes has taken a big step forward.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Different methods of bariatric surgery ameliorate type 2 diabetes to varying degrees.

References

  1. Thaler, J.P. & Cummings, D.E. Endocrinology 150, 2518–2525 2009).

    Article  CAS  Google Scholar 

  2. Rubino, F., Schauer, P.R., Kaplan, L.M. & Cummings, D.E. Annu. Rev. Med. 61, 393–411 2010).

    Article  CAS  Google Scholar 

  3. Rubino, F., Kaplan, L.M., Schauer, P.R. & Cummings, D.E. Ann. Surg. 251, 399–405 2010).

    Article  Google Scholar 

  4. Zimmet, P., Alberti, K.G., Rubino, F. & Dixon, J.B. Lancet 378, 108–110 2011).

    Article  Google Scholar 

  5. NIH. Ann. Intern. Med. 115, 956–961 1991).

  6. Mingrone, G. et al. N. Engl. J. Med. doi:10.1056/NEJMoa1200111 (26 March 2012).

  7. Schauer, P.R. et al. N. Engl. J. Med. doi: 10.1056/NEJMoa1200225 (26 March 2012).

  8. Sjöström, L. et al. N. Engl. J. Med. 351, 2683–2693 2004).

    Article  Google Scholar 

  9. Sjöström, L. et al. J. Am. Med. Assoc. 307, 56–65 2012).

    Article  Google Scholar 

  10. Sjöström, L. et al. N. Engl. J. Med. 357, 741–752 2007).

    Article  Google Scholar 

  11. Adams, T.D. et al. N. Engl. J. Med. 357, 753–761 2007).

    Article  CAS  Google Scholar 

  12. Manson, J.E. et al. N. Engl. J. Med. 349, 523–534 2003).

    Article  CAS  Google Scholar 

  13. Gerstein, H.C. et al. N. Engl. J. Med. 358, 2545–2559 2008).

    Article  CAS  Google Scholar 

  14. Buchwald, H. et al. J. Am. Med. Assoc. 292, 1724–1737 2004).

    Article  CAS  Google Scholar 

  15. Rejeski, W.J. et al. N. Engl. J. Med. 366, 1209–1217 2012).

    Article  CAS  Google Scholar 

  16. Dixon, J.B. et al. J. Am. Med. Assoc. 299, 316–323 2008).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David E Cummings.

Ethics declarations

Competing interests

Dr. Cummings is a Principal Investigator on the COSMID trial, which is funded by Johnson & Johnson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cummings, D. Metabolic surgery for type 2 diabetes. Nat Med 18, 656–658 (2012). https://doi.org/10.1038/nm.2773

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2773

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing